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Abstract We assessed the frequency of carriers of methicillin-
resistant Staphylococcus aureus (MRSA) among 500 dental
patients of a university clinic. From each participant, two
specimens were taken from the anterior nares and the pharynx
and analysed by culture. The participants completed a
questionnaire on possible risk factors of MRSA infection.
Two hundred ten individuals carried S. aureus, 90 in the nares
only, 51 in the throat only and 69 in nares and throat. Isolates
of 208 patients were methicillin-sensitive; two isolates were
methicillin-resistant, both carried in the throat exclusively. In
conclusion, the frequency of nasal and/or throat carriers of
MRSA among dental patients was low and suggests few
opportunities of exposure in the dental clinic assessed.
Keywords Staphylococcus aureus . Methicillin resistance .
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Introduction
Staphylococcus aureus is an important bacterial pathogen
causing a wide variety of infections ranging from mild local
infections of skin and soft tissue to severe systemic
infections such as sepsis and toxic shock syndrome, which
may be lethal. Typically, this bacterium lives as a
commensal in the nose and/or throat of 20% to 70% of
adults [17, 31]. Methicillin-resistant S. aureus (MRSA)
which are generally resistant to multiple antibiotics have
emerged among persons in hospitals, nursing homes and
other health care institutions since the 1960s and are called
hospital- or health care-associated MRSA (HA-MRSA) [2].
They account for a large part of nosocomial infections
worldwide [29, 33] and are associated with longer hospital-
isation and higher lethality [37]. Most of these nosocomial
infections are caused by few successful epidemic clones of
HA-MRSA [20].
In the community setting, several outbreaks of severe
infections with MRSA have been reported among people
lacking established risk factors for HA-MRSA acquisition
[6]. The bacteria are referred to as community-associated
MRSA (CA-MRSA) and differ from HA-MRSA in several
important aspects [9, 44]. First reported in the 1980s, these
CA-MRSA infections seem to have increased in prevalence
in the past several years, affecting children and adult
populations as diverse as aboriginal communities in
Australia, military recruits, individuals involved in contact
team sports, prisoners or intravenous drug users [22, 44].
CA-MRSA caused predominantly skin and soft tissue
infections [32], but was also associated with severe
pulmonary infections including fatal necrotising pneumonia
and empyema [24]. Recent increases in CA-MRSA infec-
tions in the USA appear to be associated with a few strains
of S. aureus [22], some of which have recently disseminat-
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ed in Denmark [27], whilst other European isolates were
found to be genetically more diverse [3, 15].
In hospitals, MRSA are transmitted by indirect or direct
contact mainly, but transmission by droplets or rarely
airborne dispersal has been observed among health care
workers [36]. Many hospitals have successfully introduced
concerted measures to reduce HA-MRSA prevalence,
including meticulous hand disinfection after every patient
contact as well as early detection of carriers and their
decontamination [5, 11, 43]. Guidelines and/or surveillance
strategies have been set up at national levels [19, 41]. Direct
contact is also the most common mode of transmission of
CA-MRSA.
Prevention efforts in specific populations and circum-
stances should optimally be guided by epidemiological data
not available in the dental setting. MRSA proportion in
hospitals varies considerably among countries: about 1% in
the Nordic countries and The Netherlands, >40% in
southern Europe (Portugal, Italy, Turkey) [14, 42] and
25% to >60% in the USA [33]. Switzerland exhibits a low
prevalence of MRSA in hospitals (on the average 2%), but
the distribution is heterogeneous (Geneva >30% MRSA)
[4, 16].
The aim of this study was to determine the MRSA
carrier rate among dental patients as representation of the
Basel general population by a prospective prevalence study
allowing targeted infection control in dental practice.
Materials and methods
From August to November 2006, 500 volunteers were
recruited among the adult patients of the Department of
Oral Surgery, Dental School, University of Basel. The only
exclusion criterion was age <18 years. The test persons
were informed on the study verbally and in writing and
gave written informed consent. The study had been
approved by the Basel State Ethical Committee (protocol
no. 232/04). All participating individuals completed a
questionnaire including personal data and medical history
as well as questions on possible risk factors for MRSA
carriage.
Two specimens were obtained with sterile polyester
fibre-tipped swabs moistened with sterile saline from the
anterior nares (three rotations in each anterior nostril) and
from the posterior wall of the pharynx. The samples were
taken by a dentist who had been appropriately trained.
Swabs were brought to the microbiology laboratory in a
transport medium (Venturi Transystem, Copan, Italy). Within
4 h, the swabs were inoculated into a selective enrichment
broth (brain heart infusion broth with 6% NaCl, Axonlab,
Baden, Switzerland). After incubation at 35°C overnight, the
broth was subcultured on both a chromogenic agar for S.
aureus (S. aureus ID Agar, bioMérieux, France) and a blood
agar plate (Columbia with 5% sheep blood, Becton
Dickinson, Heidelberg, Germany) for 24 h.
Colonies suspicious of S. aureus were identified on the
basis of several traits such as typical colonies on the
chromogenic agar and blood agar plus presence of clumping
factor, protein A and capsular antigens as determined by an
agglutination test (Slidex Staph Plus, bioMérieux, France).
Methicillin sensitivity of all S. aureus isolates was examined
by agar diffusion on Mueller–Hinton agar using a cefoxitin
disk according to the guidelines of the Clinical and
Laboratory Standards Institute [21]. Data analyses were
performed using SPSS software (SPSS, Chicago, USA).
Level of significance was p<0.05.
Results
More than 90% of the patients asked participated voluntar-
ily in the study. The median age was 48.5 years (range 18–
91 years) among the 500 individuals screened. The gender
of participants was equally distributed (women 49.2%, men
50.8%).
S. aureus was isolated from 210 test persons (42%;
Table 1). Of particular interest is the group of 51
individuals (10.2%) who were exclusive throat carriers.
Isolates of 208 individuals (41.6%) were sensitive to
methicillin (MSSA), whilst two throat isolates (0.4%) were
MRSA (Table 1). Data from the two MRSA carriers, a
woman and a man, are shown in Table 2. The number of
MRSA carriers was too small to find statistically significant
associations. Both MRSA-positive participants were offered
a successful decolonisation treatment [8], but neither of
them responded to attempts by multiple telephone calls and
letters.
Discussion
The prevalence of colonisation with S. aureus in this
population of dental patients (42%) was in the range
Table 1 S. aureus carrier rates among the 500 dental patients studied
n (%)
S. aureus carriage, overall 210 (42%)
Nasal carriage 159 (31.9%)
Throat carriage 120 (24%)
Nasal and throat carriage 69 (13.9%)
Exclusive nasal carriage 90 (18%)
Exclusive throat carriage 51 (10.2%)
MSSA carriage 208 (41.6%)
MRSA carriage in throat 2 (0.4%)
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determined in other populations in Europe and in the USA
[33]. It was slightly lower than in other collectives
examined in the Basel region with closer ties to the health
care system (i.e. blood donors 54%, health care workers
48%) [31].
The anterior nares are known to be the primary colonisation
site of S. aureus [18]. In this study, 51 people, i.e. 10.2% of
those tested and 24.2% of the carriers, harboured S. aureus
exclusively in the throat. In addition, the two MRSA-positive
individuals carried these staphylococci in the throat, not in
the nares. These findings support the postulate that screening
for S. aureus carriers should include swabs from nares and
throat to improve detection [31]. Recently, it has been
suggested that colonisation sites other than the anterior nares
play an important role in the development of CA-MRSA
infection; genital without nasal colonisation has also been
reported [10].
The MRSA prevalence among individuals seeking dental
treatment in Basel is low (0.4%) as has been reported (0.2–
1.3%) among community members [35]. However, MRSA
is the most common pathogen in US emergency rooms in
patients with skin and soft tissue infections. Therefore,
infection control activities should be initiated before the
problem of CA-MRSA becomes endemic. In fact, Geneva
already experienced the first outbreak of CA-MRSA in the
community [28].
The number of MRSA carriers in this population was too
low to draw firm conclusions with respect to risk factors for
CA-MRSA colonisation. However, both MRSA carriers
were young, appeared to be immunologically competent
and had few contacts to the health care system in the past
12 months, which was thought to be typical [9, 32], but
may apply to only a subset of CA-MRSA infections [12].
However, these criteria have been defined based on
infections, and to our knowledge, it has not been
established if they are applicable to carriers as well. We
had intended to genotype the two isolates by determining
the spa and pulsed-field types in order to compare them to
the genotypes prevalent in the nearby university hospital
[15]. Unfortunately, both isolates were lost by accident and
re-isolation was not possible because the two carriers did
not respond to the offers of decolonisation treatment.
Carriage of MRSA in the nose and/or throat of patients
or dentists may not represent the only reservoir for
transmission within the dental office. Recent data suggested
that presence of S. aureus in the oral cavity may be more
frequent than previously thought [13, 39]. The proportion
of MRSA among 1,017 S. aureus isolates from 5,005 oral
specimens was 6% in a study from Scotland [40], and S.
aureus (sensitivity to methicillin not determined) has
recently been linked to peri-implant infections in a study
from Sweden [34].
MRSA are most frequently spread via transiently
contaminated hands of health care professionals, but
contaminated surfaces and objects may play a minor role
in MRSA transmission [26]. Infection control in the dental
practice is regulated by national guidelines [1, 7, 23, 25].
These hygiene measures are designed to safeguard the
health and safety of both patients and staff, in particular to
prevent the transmission of blood-borne infections, primar-
ily hepatitis B or C viruses, as well as infectious agents
spread by contact or droplets, e.g.Mycobacterium tuberculosis.
Standard precautions are considered effective to prevent
MRSA transmission to the dental team and from patient to
patient [7, 26, 38]. In particular, strict adherence to hand
disinfection before and after every patient contact and wearing
personal protection equipment (gloves, mask, gown, eye
protection) are recommended [1, 38].
Nevertheless, as long as the MRSA carrier rates in the
general population are low and infection control measures
are followed strictly, we consider visit to a dentist not as a
risk factor for the spreading of CA-MRSA. Other risk
factors appear dominant [35]. However, dentists themselves
may become a source of transmission. To our knowledge,
there is only documented transmission of MRSA from a
dentist whose nares had been colonised to two patients in
Table 2 Characteristics of the
two MRSA carriers Sex Male Female
Age (years) 25 29
Nationality Swiss Swiss
Other people living in the same household 2 2
Reason for visiting the Department of Oral Surgery Pain because of apical
periodontitis
Pain because of apical
periodontitis
Suffering from chronic disease No Epilepsy
History of skin soft tissue infection No No
Hospitalisation in the past 12 months No 4 days (gynaecology)
Antibiotic treatment in the past 12 months No No
Ever used drugs (iv or inhaled) No No
Playing a contact sport No No
Accommodation in a camp in the past year No No
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England [30]. However, this had occurred before standard
infection control practices were instituted in that practice
[30].
In conclusion, the frequency of nasal and/or throat carriers
of MRSA among dental patients in Basel, Switzerland was
low. The results suggest few opportunities of exposure in the
dental office. However, more data are needed to evaluate the
epidemiology of MRSA and their role in the healthy and
diseased oral cavity.
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